By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sandoz GmbH 

Wagramer Str. 19

Vienna    1220  Austria
Phone: 43-1-26-068-0 Fax: n/a



Company News
Sandoz GmbH Testimony at FDA Hearing on Biosimilars Will Emphasize Need for Consistent Regulatory Standards Across All Biologics 5/9/2012 10:46:44 AM
Novartis AG Unit Recalling Prescription Eye Drops 7/21/2008 7:49:53 AM
Altus Pharmaceuticals Inc. (ALTU) Secures Long-Term Growth Hormone Supply For ALTU-238 Clinical Development and Commercialization 7/10/2008 10:19:04 AM
LifeCycle Pharma Announces Successful Completion of Pilot Studies on LCP-Feno and is Currently Preparing for Pivotal Studies 5/28/2008 10:26:43 AM
FDA Warns Drugmakers Over Unapproved Headache Drugs, Companies Include: Novartis Pharma AG (NVS), Sandoz GmbH, IVAX Pharmaceuticals, Inc. (IVX), and Teva Pharmaceutical Industries Limited (TEVA) 3/2/2007 11:40:21 AM
Barr Pharmaceuticals, Inc. (BRL) To Pay 22.5 Million USD To Settle Warfarin Law Suit With Novartis Corporation (NVS) Units 6/12/2006 10:56:39 AM
340B Prime Vendor Program Adds Sandoz Pharmaceuticals To Growing List Of Companies Providing Low-Income Americans With Access To Antibiotic Injectibles And Oral Solid Medications 4/11/2006 12:09:28 PM
FDA Rebuffs Novartis Pharma AG (NVS) Over Delay To Biogeneric Drug 11/15/2005 11:16:25 AM
Novartis India Limited (NVS) To Sell Anti-TB Bulk Drug Business To Sandoz Private Limited10/19/2005 5:13:04 PM
Novartis India Limited (NVS) Plans To Sell Rifampicin Business To Sandoz10/19/2005 5:12:34 PM